NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

64 hedge funds and large institutions have $18.4M invested in NeuBase Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.55M
Puts
$871K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$4.51M
2
$1.55M
3
$1.53M
4
$941K
5
$727K
6
$655K
7
$608K
8
$597K
9
$521K
10
$496K
11
$484K
12
$476K
13
$455K
14
$409K
15
$329K
16
$272K
17
$233K
18
$231K
19
$217K
20
$209K
21
$190K
22
$185K
23
$176K
24
$166K
25
$158K